Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pantera (specifically Pantera Lux) is a paclitaxel-eluting drug-coated balloon (DCB) catheter developed by Biotronik. It is a drug-device combination used in interventional cardiology to treat coronary artery disease, specifically in-stent restenosis (ISR) and ST-segment elevation myocardial infarction (STEMI). The device delivers a 3.0 µg/mm² dose of paclitaxel, a taxane that inhibits neointimal proliferation by stabilizing microtubules and preventing smooth muscle cell division. The balloon surface utilizes butyryltri-n-hexyl citrate (BTHC) as an excipient to optimize the transfer and retention of paclitaxel in the vessel wall. Clinical evaluations, including trials coordinated by Diagram B.V., have investigated its efficacy as a pre-dilatation tool prior to stent implantation to reduce restenosis rates.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pantera Lux.